Prostate Cancer
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? - Abstract
December 21, 2012
Current status of brachytherapy for prostate cancer - Abstract
December 21, 2012
Body mass index influences prostate cancer risk at biopsy in Japanese men - Abstract
December 21, 2012
Prostate cancer may trigger paraneoplastic limbic encephalitis: A case report and a review of the literature - Abstract
December 21, 2012
Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site - Abstract
December 21, 2012
The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: A systematic review - Abstract
December 21, 2012
Outcomes and trends of prostate biopsy for prostate cancer in chinese men from 2003 to 2011 - Abstract
December 21, 2012
Status and medicolegal implications in France pT0 stage of prostate cancer: A study by the CC-AFU - Abstract
December 20, 2012
Progress in gene therapy for prostate cancer - Abstract
December 20, 2012
Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy - Abstract
December 20, 2012
Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy - Abstract
December 20, 2012
Abiraterone acetate for the treatment of prostate cancer - Abstract
December 20, 2012
Clinical commissioning of online seed matching protocol for prostate radiotherapy - Abstract
December 19, 2012
Migration of pathological stage after radical prostatectomy to higher risk tumors of relapse: Comparative two-center study between 2005 and 2010 - Abstract
December 19, 2012